Skip to main content

Advertisement

ADVERTISEMENT

News

AmnioWrap2 - BioStem Technologies

https://www.globenewswire.com/news-release/2024/06/26/2904491/0/en/BioStem-Technologies-Reports-Breakthrough-Results-with-AmnioWrap2-in-Retrospective-Wound-Care-Study.html

BioStem Technology announced breakthrough results with its AmnioWrap2 proprietary retention-processed amnion chorion (RE-AC) processing method vs a laminated process. RE-AC showed a greater percent area reduction (PAR) of DFUs of 67.3% vs 52.6% at 12 weeks and required fewer applications.

Advertisement

Advertisement

Advertisement